Hone Health reports that the controversial 2002 WHI study misled menopause care, linking HRT to breast cancer and causing ...

Testosterone propionate was once a common treatment for men with low testosterone. It’s a synthetic version of the naturally ...

Pedro C. Barata, MD, MSc, discusses the advantages and disadvantages of darolutamide in metastatic hormone-sensitive prostate cancer.

Nearly half of women in the U.S. going through menopause may experience moderate to severe vasomotor symptoms due to ...

Doctors now recognize the need to approach testosterone deficiency with the same clinical rigour as other hormone ...

The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program. Dr.

Children’s National Hospital will stop prescribing gender-affirming medication, citing “escalating legal and regulatory risks ...